Robin Shattock, PhD, Chair

Dr. Shattock is professor of cellular and molecular infection in the Department of Cellular and Molecular Medicine, St. George's Hospital Medical School, University of London. He directs a research group working on the pathogenesis and transmission of HIV infection, with a particular emphasis on the development of prevention strategies applicable to the developing world.

His research group has been instrumental in elucidating the early mechanism of HIV transmission, which is being used in a translational fashion to develop safe and effective vaginal microbicides and to explore novel HIV vaccination strategies. Dr. Shattock’s group receives funding from the Wellcome Trust, the Bill & Melinda Gates Foundation, the European Commission, the US National Institutes of Health and IPM.

Dr. Shattock coordinates the European Vaccines and Microbicides Enterprise network of Europrise, leads the Mucosal Discovery Team of Center for HIV Vaccine Immunology (CHAVI), and co-coordinates the scientific direction of the European Microbicides Program on Combined Highly Active Antiretroviral Microbicides (CHAARM).